Fidelity evaluation of the dialogue around respiratory illness treatment (DART) program communication training.

2022

2022 Mar 14

1873-5134

<p><strong>OBJECTIVE: </strong>To evaluate receipt fidelity of communication training content included in a multifaceted intervention known to reduce antibiotic over-prescribing for pediatric acute respiratory tract infections (ARTIs), by examining the degree to which clinicians implemented the intended communication behavior changes.</p>

<p><strong>METHODS: </strong>Parents were surveyed regarding clinician communication behaviors immediately after attending 1026 visits by children 6 months to &lt;&nbsp;11 years old diagnosed with ARTIs by 53 clinicians in 18 pediatric practices. Communication outcomes analyzed were whether clinicians: (A) provided both a combined (negative + positive) treatment recommendation and a contingency plan (full implementation); (B) provided either a combined treatment recommendation or a contingency plan (partial implementation); or (C) provided neither (no implementation). We used mixed effects multinomial logistic regression to determine whether these 3 communication outcomes changed between baseline and the time periods following each of 3 training modules.</p>

<p><strong>RESULTS: </strong>After completing the communication training, the adjusted probability of clinicians fully implementing the intended communication behavior changes increased by an absolute 8.1% compared to baseline (95% Confidence Interval [CI]: 2.4%, 13.8%, p&nbsp;=&nbsp;.005).</p>

<p><strong>CONCLUSIONS: </strong>Our findings support the receipt fidelity of the intervention's communication training content.</p>

<p><strong>PRACTICAL IMPLICATIONS: </strong>Clinicians can be trained to implement communication behaviors that may aid in reducing antibiotic over-prescribing for ARTIs.</p>

10.1016/j.pec.2022.03.011

Patient Educ Couns

35341612

Reducing Antibiotic Prescribing in Primary Care for Respiratory Illness.

2020

2020 Aug 03

1098-4275

<p><strong>BACKGROUND: </strong>One-third of outpatient antibiotic prescriptions for pediatric acute respiratory tract infections (ARTIs) are inappropriate. We evaluated a distance learning program's effectiveness for reducing outpatient antibiotic prescribing for ARTI visits.</p>

<p><strong>METHODS: </strong>In this stepped-wedge clinical trial run from November 2015 to June 2018, we randomly assigned 19 pediatric practices belonging to the Pediatric Research in Office Settings Network or the NorthShore University HealthSystem to 4 wedges. Visits for acute otitis media, bronchitis, pharyngitis, sinusitis, and upper respiratory infection for children 6 months to &lt;11 years old without recent antibiotic use were included. Clinicians received the intervention as 3 program modules containing online tutorials and webinars on evidence-based communication strategies and antibiotic prescribing, booster video vignettes, and individualized antibiotic prescribing feedback reports over 11 months. The primary outcome was overall antibiotic prescribing rates for all ARTI visits. Mixed-effects logistic regression compared prescribing rates during each program module and a postintervention period to a baseline control period. Odds ratios were converted to adjusted rate ratios (aRRs) for interpretability.</p>

<p><strong>RESULTS: </strong>Among 72 723 ARTI visits by 29 762 patients, intention-to-treat analyses revealed a 7% decrease in the probability of antibiotic prescribing for ARTI overall between the baseline and postintervention periods (aRR 0.93; 95% confidence interval [CI], 0.90-0.96). Second-line antibiotic prescribing decreased for streptococcal pharyngitis (aRR 0.66; 95% CI, 0.50-0.87) and sinusitis (aRR 0.59; 95% CI, 0.44-0.77) but not for acute otitis media (aRR 0.93; 95% CI, 0.83-1.03). Any antibiotic prescribing decreased for viral ARTIs (aRR 0.60; 95% CI, 0.51-0.70).</p>

<p><strong>CONCLUSIONS: </strong>This program reduced antibiotic prescribing during outpatient ARTI visits; broader dissemination may be beneficial.</p>

10.1542/peds.2020-0038

Pediatrics

32747473